{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:11:34Z","timestamp":1790964694052,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.tem.2016.05.005","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T20:11:49Z","timestamp":1466453509000},"page":"643-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics"],"prefix":"10.1016","volume":"27","author":[{"given":"Bernhard","family":"Mayr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Glaudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Sch\u00f6fl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2016.05.005_bib0005","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1530\/EJE-15-1028","article-title":"Genetics in endocrinology: gain and loss of function mutations of the calcium sensing receptor and associated proteins: current treatment concepts","volume":"174","author":"Mayr","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2016.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.tem.2016.05.005_bib0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00223-015-0052-z","article-title":"Calcimimetic and calcilytic drugs: feats, flops, and futures","volume":"98","author":"Nemeth","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tem.2016.05.005_bib0020","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1582-4934.2007.00096.x","article-title":"Structure and function of the human calcium-sensing receptor: insights from natural and engineered mutations and allosteric modulators","volume":"11","author":"Hu","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.tem.2016.05.005_bib0025","doi-asserted-by":"crossref","first-page":"51739","DOI":"10.1074\/jbc.M406164200","article-title":"The venus fly trap domain of the extracellular Ca2+-sensing receptor is required for L-amino acid sensing","volume":"279","author":"Mun","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.05.005_bib0030","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/cr.2016.36","article-title":"Towards a structural understanding of allosteric drugs at the human calcium-sensing receptor","volume":"26","author":"Leach","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.tem.2016.05.005_bib0035","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm1154","article-title":"Extracellular calcium sensing and signalling","volume":"4","author":"Hofer","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tem.2016.05.005_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1476-5381.2011.01511.x","article-title":"New concepts in calcium-sensing receptor pharmacology and signalling","volume":"165","author":"Ward","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tem.2016.05.005_bib0045","doi-asserted-by":"crossref","first-page":"19537","DOI":"10.1074\/jbc.271.32.19537","article-title":"Expression and characterization of inactivating and activating mutations in the human Ca2+-sensing receptor","volume":"271","author":"Bai","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.05.005_bib0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.beem.2013.03.003","article-title":"The calcium sensing receptor life cycle: trafficking, cell surface expression, and degradation","volume":"27","author":"Breitwieser","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2016.05.005_bib0060","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1210\/en.2006-1035","article-title":"Functional desensitization of the extracellular calcium-sensing receptor is regulated via distinct mechanisms: role of G protein-coupled receptor kinases, protein kinase C and beta-arrestins","volume":"148","author":"Lorenz","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.05.005_bib0065","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1210\/me.2011-1370","article-title":"Minireview: the intimate link between calcium sensing receptor trafficking and signaling: implications for disorders of calcium homeostasis","volume":"26","author":"Breitwieser","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.tem.2016.05.005_bib0070","doi-asserted-by":"crossref","first-page":"ra78","DOI":"10.1126\/scisignal.2002208","article-title":"Agonist-driven maturation and plasma membrane insertion of calcium-sensing receptors dynamically control signal amplitude","volume":"4","author":"Grant","year":"2011","journal-title":"Sci. Signal."},{"key":"10.1016\/j.tem.2016.05.005_bib0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/EJE-10-0907","article-title":"A novel mutation of the primary protein kinase C phosphorylation site in the calcium-sensing receptor causes autosomal dominant hypocalcemia","volume":"164","author":"Lazarus","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2016.05.005_bib0080","doi-asserted-by":"crossref","first-page":"31355","DOI":"10.1074\/jbc.272.50.31355","article-title":"The carboxyl terminus of the human calcium receptor. Requirements for cell-surface expression and signal transduction","volume":"272","author":"Ray","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.05.005_bib0085","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2016.05.005_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/er.2009-0043","article-title":"The calcium-sensing receptor: a molecular perspective","volume":"32","author":"Magno","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2016.05.005_bib0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.beem.2013.02.010","article-title":"The extracellular calcium-sensing receptor, CaSR, in fetal development","volume":"27","author":"Riccardi","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0100","doi-asserted-by":"crossref","first-page":"F518","DOI":"10.1152\/ajprenal.00208.2015","article-title":"Comparative expression of the extracellular calcium-sensing receptor in the mouse, rat, and human kidney","volume":"310","author":"Graca","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tem.2016.05.005_bib0105","doi-asserted-by":"crossref","first-page":"F399","DOI":"10.1152\/ajprenal.00346.2001","article-title":"Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs","volume":"283","author":"Motoyama","year":"2002","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tem.2016.05.005_bib0110","doi-asserted-by":"crossref","DOI":"10.1038\/nrneph.2016.59","article-title":"Localization and function of the renal calcium-sensing receptor","author":"Riccardi","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.tem.2016.05.005_bib0115","doi-asserted-by":"crossref","first-page":"E915","DOI":"10.1152\/ajpendo.00315.2009","article-title":"The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion","volume":"297","author":"Kantham","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0120","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI57407","article-title":"PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor","volume":"122","author":"Loupy","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tem.2016.05.005_bib0125","doi-asserted-by":"crossref","first-page":"F1200","DOI":"10.1152\/ajprenal.00352.2014","article-title":"Conditionally immortalized human proximal tubular epithelial cells isolated from the urine of a healthy subject express functional calcium-sensing receptor","volume":"308","author":"Di Mise","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.tem.2016.05.005_bib0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1523-1755.1998.00790.x","article-title":"Extracellular Mg2+- and Ca2+-sensing in mouse distal convoluted tubule cells","volume":"53","author":"Bapty","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.tem.2016.05.005_bib0135","first-page":"F198","article-title":"Extracellular Ca2+ decreases chloride reabsorption in rat CTAL by inhibiting cAMP pathway","volume":"275","author":"De Jesus Ferreira","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.tem.2016.05.005_bib0140","doi-asserted-by":"crossref","first-page":"30337","DOI":"10.1074\/jbc.M201804200","article-title":"Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D","volume":"277","author":"Canaff","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.05.005_bib0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jcp.22.3.287","article-title":"The urinary calcium\u2013creatinine ratio as a measure of urinary calcium excretion","volume":"22","author":"Wills","year":"1969","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.tem.2016.05.005_bib0150","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0002-9343(77)90873-7","article-title":"Family studies in patients with primary parathyroid hyperplasia","volume":"62","author":"Marx","year":"1977","journal-title":"Am. J. Med."},{"key":"10.1016\/j.tem.2016.05.005_bib0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1194-303","article-title":"Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation","volume":"8","author":"Pollak","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tem.2016.05.005_bib0160","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2016.05.005_bib0165","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s00467-011-1871-4","article-title":"Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects","volume":"26","author":"Seyberth","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.tem.2016.05.005_bib0170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3345\/kjp.2015.58.4.148","article-title":"Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C","volume":"58","author":"Choi","year":"2015","journal-title":"Korean J. Pediatr."},{"key":"10.1016\/j.tem.2016.05.005_bib0175","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(02)09842-2","article-title":"Association between activating mutations of calcium-sensing receptor and Bartter's syndrome","volume":"360","author":"Watanabe","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2016.05.005_bib0180","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2265.2011.04142.x","article-title":"Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia \u2013 a German survey","volume":"75","author":"Raue","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2016.05.005_bib0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2265.2003.01869.x","article-title":"Extracellular calcium-sensing receptor dysfunction is associated with two new phenotypes","volume":"59","author":"Sayer","year":"2003","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2016.05.005_bib0190","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2169\/internalmedicine.52.8375","article-title":"Extrapyramidal symptoms and advanced calcification of the basal ganglia in a patient with autosomal dominant hypocalcemia","volume":"52","author":"Kurozumi","year":"2013","journal-title":"Intern. Med."},{"key":"10.1016\/j.tem.2016.05.005_bib0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000303188","article-title":"Phenotypic variation in a large family with autosomal dominant hypocalcaemia","volume":"74","author":"Sorheim","year":"2010","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.tem.2016.05.005_bib0200","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/apa.12743","article-title":"Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcaemia and literature review","volume":"103","author":"Thim","year":"2014","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.tem.2016.05.005_bib0205","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1210\/jc.2013-3430","article-title":"Functional activities of mutant calcium-sensing receptors determine clinical presentations in patients with autosomal dominant hypocalcemia","volume":"99","author":"Kinoshita","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0210","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/dds105","article-title":"Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites","volume":"21","author":"Hannan","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tem.2016.05.005_bib0215","volume":"28","author":"Hannan","year":"2012","journal-title":"Endocrine Abstracts"},{"key":"10.1016\/j.tem.2016.05.005_bib0220","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1006\/mgme.2000.3096","article-title":"Three novel activating mutations in the calcium-sensing receptor responsible for autosomal dominant hypocalcemia","volume":"71","author":"Conley","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0225","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2007-0322","article-title":"Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population","volume":"92","author":"Nissen","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0230","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2265.1996.750891.x","article-title":"Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis","volume":"45","author":"Pearce","year":"1996","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.tem.2016.05.005_bib0235","doi-asserted-by":"crossref","first-page":"37917","DOI":"10.1074\/jbc.M506263200","article-title":"Delineating a Ca2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor","volume":"280","author":"Silve","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2016.05.005_bib0240","doi-asserted-by":"crossref","first-page":"e113622","DOI":"10.1371\/journal.pone.0113622","article-title":"Role of Ca2+ and L-Phe in regulating functional cooperativity of disease-associated \u2018toggle\u2019 calcium-sensing receptor mutations","volume":"9","author":"Zhang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.tem.2016.05.005_bib0245","first-page":"1695","article-title":"A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia","volume":"85","author":"Lienhardt","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0250","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-15-1216","article-title":"Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study","volume":"174","author":"Obermannova","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2016.05.005_bib0255","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1056\/NEJMc1300278","article-title":"Germline mutations affecting Galpha11 in hypoparathyroidism","volume":"368","author":"Mannstadt","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2016.05.005_bib0260","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0265","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2016.05.005_bib0270","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2797","article-title":"Identification of a G-protein subunit-alpha11 gain-of-function mutation, Val340Met, in a family with autosomal dominant hypocalcemia type 2 (ADH2)","author":"Piret","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2016.05.005_bib0275","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1210\/en.2012-1449","article-title":"Identification of molecular phenotypes and biased signaling induced by naturally occurring mutations of the human calcium-sensing receptor","volume":"153","author":"Leach","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.05.005_bib0280","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1210\/en.2012-1887","article-title":"Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators","volume":"154","author":"Leach","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.05.005_bib0285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1507\/endocrj.50.91","article-title":"A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene","volume":"50","author":"Chikatsu","year":"2003","journal-title":"Endocr. J."},{"key":"10.1016\/j.tem.2016.05.005_bib0290","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/jc.2002-020081","article-title":"Autosomal dominant hypocalcemia: a novel activating mutation (E604K) in the cysteine-rich domain of the calcium-sensing receptor","volume":"88","author":"Tan","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0295","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0300","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.tem.2016.05.005_bib0305","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jbmr.2551","article-title":"Calcilytic ameliorates abnormalities of mutant calcium-sensing receptor (CaSR) knock-in mice mimicking autosomal dominant hypocalcemia (ADH)","volume":"30","author":"Dong","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2016.05.005_bib0310","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1210\/jc.2005-2605","article-title":"A hypocalcemic child with a novel activating mutation of the calcium-sensing receptor gene: successful treatment with recombinant human parathyroid hormone","volume":"91","author":"Mittelman","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0315","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.4158\/EP12132.CR","article-title":"Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report","volume":"19","author":"Gonzales","year":"2013","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.tem.2016.05.005_bib0320","article-title":"Teriparatide as a novel therapeutic option in the treatment of ADH \u2013 a case report","volume":"123","author":"Schellhaas","year":"2015","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.tem.2016.05.005_bib0325","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1359\/jbmr.081233","article-title":"PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation","volume":"24","author":"Theman","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2016.05.005_bib0330","doi-asserted-by":"crossref","first-page":"10876","DOI":"10.1074\/jbc.M115.696401","article-title":"Allosteric modulation of the calcium-sensing receptor rectifies signaling abnormalities associated with G-protein alpha-11 mutations causing hypercalcemic and hypocalcemic disorders","volume":"291","author":"Babinsky","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.tem.2016.05.005_bib0335","first-page":"SA0002","article-title":"Treatment of autosomal dominant hypocalcemia with the calcilytic NPSP795","volume":"30","author":"Ramnitz","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2016.05.005_bib0340","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4155\/fmc.11.17","article-title":"Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis","volume":"3","author":"Widler","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.tem.2016.05.005_bib0345","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/en.2015-1269","article-title":"The calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing receptor (CaSR) mutation: relevance to autosomal dominant hypocalcemia type 1 (ADH1)","volume":"156","author":"Hannan","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2016.05.005_bib0350","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.0405516101","article-title":"Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification","volume":"101","author":"Hough","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tem.2016.05.005_bib0355","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bone.2013.05.021","article-title":"Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmenopausal women","volume":"56","author":"Caltabiano","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.tem.2016.05.005_bib0360","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1210\/jc.2010-2855","article-title":"The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density","volume":"96","author":"Fitzpatrick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0365","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2009.09.028","article-title":"An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation","volume":"46","author":"Kumar","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.tem.2016.05.005_bib0370","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00198-015-3392-7","article-title":"A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates","volume":"27","author":"Cosman","year":"2016","journal-title":"Osteoporosis Int."},{"key":"10.1016\/j.tem.2016.05.005_bib0375","first-page":"89","article-title":"Antagonist for calcium-sensing receptor: JTT-305\/MK-5442","volume":"21","author":"Fukumoto","year":"2011","journal-title":"Clin. Calcium"},{"key":"10.1016\/j.tem.2016.05.005_bib0380","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bone.2014.04.015","article-title":"AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women","volume":"64C","author":"John","year":"2014","journal-title":"Bone"},{"issue":"Suppl. 1","key":"10.1016\/j.tem.2016.05.005_bib0385","first-page":"A1051","article-title":"Characterization of the effect of ronacaleret, a calcium-sensing receptor antagonist, on renal calcium excretion","volume":"24","author":"Caltabiano","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2016.05.005_bib0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jbmr.554","article-title":"Ronacaleret, a calcium-sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women","volume":"27","author":"Fitzpatrick","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2016.05.005_bib0395","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bone.2011.06.017","article-title":"Ronacaleret, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time: results of a randomized, double-blinded, placebo-controlled Phase II clinical trial","volume":"49","author":"Fitzpatrick","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.tem.2016.05.005_bib0400","doi-asserted-by":"crossref","first-page":"E2207","DOI":"10.1210\/jc.2013-4009","article-title":"A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis","volume":"99","author":"Halse","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.tem.2016.05.005_bib0405","first-page":"A1130","article-title":"Ronacaleret, a calcium-sensing receptor antagonist: results of a 1 year double-blind, placebo-controlled, dose-ranging phase II study","volume":"24","author":"Fitzpatrick","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2016.05.005_bib0410","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.beem.2013.05.005","article-title":"CaSR function in the intestine: hormone secretion, electrolyte absorption and secretion, paracrine non-canonical Wnt signaling and colonic crypt cell proliferation","volume":"27","author":"Macleod","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0415","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12035-013-8448-0","article-title":"Calcium sensing receptor absence delays postnatal brain development via direct and indirect mechanisms","volume":"48","author":"Liu","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2016.05.005_bib0420","doi-asserted-by":"crossref","first-page":"21975","DOI":"10.1038\/srep21975","article-title":"The extracellular calcium-sensing receptor regulates human fetal lung development via CFTR","volume":"6","author":"Brennan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tem.2016.05.005_bib0425","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2016-1082","article-title":"Calcium sensing receptor tumor expression and lethal prostate cancer progression","author":"Ahearn","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2016.05.005_bib0430","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3748\/wjg.v22.i9.2711","article-title":"Calcium-sensing receptor: a new target for therapy of diarrhea","volume":"22","author":"Cheng","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tem.2016.05.005_bib0435","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1196\/annals.1346.044","article-title":"Misconceptions about calcimimetics","volume":"1068","author":"Nemeth","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.tem.2016.05.005_bib0440","first-page":"A1131","article-title":"Randomized, single-blinded placebo-controlled study of a novel calcilytic, JTT-305, in patients with postmenopausal osteoporosis","volume":"24","author":"Fukumoto","year":"2009","journal-title":"J. Bone Miner. Res."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276016300509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276016300509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T03:50:14Z","timestamp":1536637814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276016300509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1043276016300509"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2016.05.005","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2016.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}